Platinum
Phase 3Small molecule
Bristol-Myers SquibbPlatinum is one of 300 small molecule programs targeting Hypopharyngeal Carcinoma. It is currently in Phase 3.
11
Indications
23
Total Trials
15
Active Trials
299
Competitors
Pipeline
Status by Indication[3][1]
Indication
Showing 10 of 11 indications
Competition
Competitive Landscape
2828 competitors in Breast Cancer
#DrugCompanyPhaseTrials
1Platinum
Bristol-Myers SquibbPhase 3
Adriamycin
GGynecologic Oncology Group
Preclinical
Prolia
AmgenPreclinical
Cymbalta
Alnylam PharmaceuticalsPreclinical
Zolymbus
AbbViePreclinical
Lupron
EEastern Cooperative Oncology Group
Preclinical
Methylthioninium Chloride
PProvepharm SAS
Preclinical
Effexor
WWyeth-Lederle Vaccines
Preclinical
Spravato
WWim Janssens
Preclinical
Chirocaine
PPurdue Pharma LP
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Small Cell Lung Cancer6 trials
Show 3 more trials
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
Not yet recruiting·—·Phase 4·NCT06951841·31 enrolled
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
Not yet recruiting·—·Phase 2·NCT07376499·31 enrolled
Lung Cancer2 trials
Cervical Cancer1 trial
Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.
Not yet recruiting·OObstetrics & Gynecology Hospital of Fudan University·Phase 2·NCT06128460·24 enrolled
Hypopharyngeal Carcinoma1 trial
12 more indications
Chemotherapy1 trial
Efficacy and Safety1 trial
First-line Treatment1 trial
Patients With Advanced Solid Tumors1 trial
Breast Cancer1 trial
Adenocarcinoma1 trial
Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma
Not yet recruiting·WWomen's Hospital School Of Medicine Zhejiang University·Phase 3·NCT06870565·238 enrolled
Non-Small Cell Lung Cancer1 trial
Advanced or Metastatic Solid Tumors1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Platinum. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company